Opportunity Information: Apply for CDC RFA GH16 1621
Apply for CDC RFA GH16 1621
- The HHS-CDC-CGH in the health sector is offering a public funding opportunity titled "Supporting the Provision of High Quality, Comprehensive, and Sustainable HIV Services in National Teaching and Referral Hospitals in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Dec 04, 2015 and posted on Dec 04, 2015.
- Applicants must submit their applications by Feb 04, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $10,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Public and State controlled institutions of higher education.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Supporting the Provision of High Quality, Comprehensive, and Sustainable HIV Services in National Teaching and Referral Hospitals in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a U.S. Centers for Disease Control and Prevention (CDC) funding announcement focused on strengthening HIV prevention, testing, and treatment services in Kenya through the country’s National Teaching and Referral Hospitals (NTRHs). The overall intent is to reduce new HIV infections and cut HIV-related illness and deaths by improving how HIV services are delivered for the general population as well as key and priority populations, while also building long-term institutional capacity in major referral hospitals that can function as national leaders in quality HIV care.
At its core, the opportunity targets the full HIV service continuum. It emphasizes increasing knowledge of HIV status, which typically means expanding and improving HIV testing services and ensuring strong linkage to care for people who test positive. Alongside diagnosis, it prioritizes preventing new infections among both adults and children, reflecting a combination of biomedical, behavioral, and service-delivery strategies that can be integrated in hospital and referral settings. The announcement also stresses high quality clinical care and antiretroviral therapy (ART) services, with viral suppression as a central performance goal. Viral suppression is highlighted because it improves individual health outcomes and reduces onward transmission, making it a key driver of both morbidity and mortality reduction and incidence decline.
A major distinguishing feature of this funding announcement is its focus on strengthening selected National Teaching and Referral Hospitals as Centers of Excellence (COEs). This means the hospitals are expected not only to provide strong direct patient services, but also to operate as hubs for mentorship, training, and capacity building for health care workers (HCWs). The aim is to improve the quality and consistency of HIV service delivery across the broader health system by leveraging these hospitals’ specialized expertise, teaching mission, and referral role. The FOA explicitly includes advanced case management as part of this capacity-building effort, signaling attention to complex patients such as those with advanced HIV disease, treatment failure, co-infections, or other clinical complications that require higher-level expertise and structured clinical support.
From an administrative and funding standpoint, this was a discretionary cooperative agreement (not a simple grant), meaning CDC would typically anticipate substantial involvement in program oversight, technical guidance, monitoring, and collaboration during implementation. The opportunity falls under the health category and is associated with CFDA number 93.067. The eligible applicants were limited to public and state-controlled institutions of higher education, which aligns with the teaching-hospital and academic-medical-center orientation of the work and the expectation that the recipient can support clinical training, mentorship models, and sustainable institutional capacity development. The funding opportunity number is CDC RFA GH16-1621, it was posted on December 4, 2015, created the same day, and had a closing date of February 4, 2016.
In terms of scale, the announcement projected a single award (expected awards: 1), with an award ceiling of $10,500,000. With only one anticipated recipient, the design implies a centralized implementation partner that would coordinate activities across targeted referral hospital sites, standardize approaches to quality improvement, and support system-wide mentorship and training functions. Overall, the opportunity is best understood as a combined service-delivery and health-system-strengthening investment under PEPFAR, using Kenya’s top-tier referral hospitals to improve HIV outcomes directly for patients and indirectly through workforce development and institutional leadership in comprehensive HIV care.
Frequently Asked Questions (FAQs)
1) What is the title of this grant opportunity?
The opportunity is titled "Supporting the Provision of High Quality, Comprehensive, and Sustainable HIV Services in National Teaching and Referral Hospitals in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR)."
2) Which U.S. agency is offering this funding?
This funding announcement is offered by the U.S. Centers for Disease Control and Prevention (CDC).
3) What is the main purpose of the opportunity?
The overall intent is to strengthen HIV prevention, testing, and treatment services in Kenya through the country’s National Teaching and Referral Hospitals (NTRHs), with the aim of reducing new HIV infections and decreasing HIV-related illness and deaths.
4) Where will the work supported by this opportunity take place?
The focus is on the Republic of Kenya, specifically through National Teaching and Referral Hospitals (NTRHs).
5) What types of HIV outcomes is this opportunity trying to improve?
The announcement emphasizes outcomes across the HIV service continuum, including increasing knowledge of HIV status, preventing new infections, improving linkage to care, strengthening antiretroviral therapy (ART) services, and achieving viral suppression as a central performance goal.
6) What does the "full HIV service continuum" mean in this funding announcement?
Based on the description provided, it refers to a connected set of services that includes HIV testing (to increase knowledge of HIV status), linkage to care for people who test positive, prevention approaches for adults and children, and high quality clinical care including ART with an emphasis on viral suppression.
7) Why is viral suppression highlighted as a key goal?
Viral suppression is emphasized because it improves individual health outcomes and reduces onward transmission. The announcement frames it as a key driver for reducing HIV-related morbidity and mortality and for lowering new HIV infections (incidence).
8) What kinds of prevention activities are emphasized?
The opportunity prioritizes preventing new infections among both adults and children, and notes that prevention may reflect a combination of biomedical, behavioral, and service-delivery strategies that can be integrated in hospital and referral settings.
9) What is meant by strengthening National Teaching and Referral Hospitals as Centers of Excellence (COEs)?
The announcement describes a model where selected NTRHs are strengthened not only to deliver strong direct patient services, but also to serve as hubs for mentorship, training, and capacity building for health care workers (HCWs). These hospitals are expected to function as national leaders in quality HIV care.
10) Are recipients expected to provide services directly to patients, or focus only on training and systems?
Both are included. The announcement positions the NTRHs as sites for strong direct patient services while also serving as hubs for mentorship, training, and broader capacity building to improve HIV service delivery beyond the hospitals themselves.
11) What is "advanced case management" in the context of this opportunity?
The funding announcement explicitly includes advanced case management as part of the capacity-building effort, signaling attention to complex patients such as those with advanced HIV disease, treatment failure, co-infections, or other clinical complications requiring higher-level expertise and structured clinical support.
12) What type of award mechanism is this?
This opportunity was a discretionary cooperative agreement rather than a simple grant.
13) What does a cooperative agreement imply about CDC's role?
The description indicates CDC would typically anticipate substantial involvement in program oversight, technical guidance, monitoring, and collaboration during implementation.
14) What is the program category for this opportunity?
The opportunity falls under the health category.
15) What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA number 93.067.
16) Who was eligible to apply?
Eligible applicants were limited to public and state-controlled institutions of higher education.
17) Why are public and state-controlled institutions of higher education the only eligible applicants?
Based on the description, this aligns with the teaching-hospital and academic-medical-center orientation of the work and the expectation that the recipient can support clinical training, mentorship models, and sustainable institutional capacity development.
18) What is the funding opportunity number?
The funding opportunity number is CDC RFA GH16-1621.
19) When was the opportunity posted and created?
It was posted on December 4, 2015, and created the same day (December 4, 2015).
20) What was the application closing date?
The closing date was February 4, 2016.
21) How many awards were expected?
The announcement projected a single award (expected awards: 1).
22) What was the maximum funding amount (award ceiling)?
The award ceiling was $10,500,000.
23) What does it mean that only one award was expected?
With only one anticipated recipient, the design implies a centralized implementation partner that would coordinate activities across targeted referral hospital sites, standardize approaches to quality improvement, and support system-wide mentorship and training functions.
24) How does PEPFAR relate to this opportunity?
The announcement is explicitly framed under the President's Emergency Plan for AIDS Relief (PEPFAR), and is described as a combined service-delivery and health-system-strengthening investment to improve HIV outcomes using Kenya’s top-tier referral hospitals.
25) What role do health care workers (HCWs) play in the project approach?
HCWs are central to the capacity-building model. The NTRHs, as Centers of Excellence, are expected to provide mentorship, training, and capacity building to improve the quality and consistency of HIV service delivery.
26) Is this opportunity focused only on the general population?
No. The intent includes improving how HIV services are delivered for the general population as well as for key and priority populations.
27) What kinds of improvements in service delivery are implied?
The description points to improvements in HIV testing and linkage to care, prevention approaches for adults and children, higher quality clinical care and ART services, and quality improvement supported by Centers of Excellence that also train and mentor the broader workforce.
28) What is the long-term capacity goal for participating hospitals?
The opportunity emphasizes building long-term institutional capacity in major referral hospitals so they can function as national leaders in high quality, comprehensive, and sustainable HIV care.
Browse more opportunities from the same agency: HHS-CDC-CGH
Browse more opportunities from the same category: Health
Next opportunity: Research to Advance Primary Care-Pharmacy Linkage for Medication Review to Reduce Older Adult Falls
Previous opportunity: Undersea Technologies for Autonomous Detection and Communications
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH16 1621
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH16 1621) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research to Advance Primary Care-Pharmacy Linkage for Medication Review to Reduce Older Adult Falls Apply for RFA CE 16 002 Funding Number: RFA CE 16 002 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $350,000 |
| Increase Access to Care for Black Men Who Have Sex with Men Apply for RFA PS 16 004 Funding Number: RFA PS 16 004 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $400,000 |
| Oral Health Service Expansion Apply for HRSA 16 076 Funding Number: HRSA 16 076 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| NHLBI Outstanding Investigator Award (OIA) (R35) Apply for RFA HL 16 024 Funding Number: RFA HL 16 024 Agency: HHS-NIH11 Category: Health Funding Amount: $500,000 |
| Scaling Integrated, Effective and Sustainable Services for the Prevention of Mother to Child HIV Transmission (PMTCT) in the Republic of Uganda under PEPFAR Apply for CDC RFA PS10 10210501SUPP16 Funding Number: CDC RFA PS10 10210501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $2,458,270 |
| Provision of comprehensive, community-based HIV/AIDS Services and Capacity Building of Indigenous Organizations in the Republic of Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10180501SUPP16 Funding Number: CDC RFA PS10 10180501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $965,884 |
| Novel Genomic Technology Development (R21) Apply for PAR 16 015 Funding Number: PAR 16 015 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Ryan White HIV/AIDS Program Part D Grants for Coordinated HIV Services and Access to Research for Women, Infants, Children, and Youth (WICY) Supplemental Apply for HRSA 16 087 Funding Number: HRSA 16 087 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| AIDS Education and Training Center National Clinician Consultation Center Apply for HRSA 16 173 Funding Number: HRSA 16 173 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Global Noncommunicable Disease Prevention and Promotion of Health Apply for CDC RFA GH14 142003CONT16 Funding Number: CDC RFA GH14 142003CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement to Support the Establishment of a Southeast Asia Regional HIV Addiction Technology Transfer Center (ATTC) (Short Title: SE Asia Regional HIV ATTC) Apply for TI 16 004 Funding Number: TI 16 004 Agency: HHS-SAMHS Category: Health Funding Amount: $250,000 |
| Strengthening HIV Clinical Services within a Network of Public and Private Health Institutions in the West, South, and North West Departments of Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1711 Funding Number: CDC RFA GH16 1711 Agency: HHS-CDC-CGH Category: Health Funding Amount: $6,000,000 |
| National Stop Transmission of Polio (NSTOP) initiative supporting polio eradication in Africa Apply for CDC RFA GH15 161202CONT16 Funding Number: CDC RFA GH15 161202CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Drug-Free Communities (DFC) Support Program Apply for SP 16 001 Funding Number: SP 16 001 Agency: HHS-SAMHS Category: Health Funding Amount: $125,000 |
| Health Systems Strengthening (HSS) Mechanism Apply for RFA 685 16 000003 Funding Number: RFA 685 16 000003 Agency: USAID-SEN Category: Health Funding Amount: $37,000,000 |
| Advanced Nursing Education Program Apply for HRSA 16 070 Funding Number: HRSA 16 070 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Services Research for Autism Spectrum Disorder across the Lifespan II (ServASD II): Pilot Research on Services for Transition-Age Youth (R34) Apply for RFA MH 17 200 Funding Number: RFA MH 17 200 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Emergency Medical Services for Children State Partnership Regionalization of Care Apply for HRSA 16 050 Funding Number: HRSA 16 050 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Increasing Access to Medication-Assisted Treatment (MAT) in Rural Primary Care Practices (R18) Apply for RFA HS 16 001 Funding Number: RFA HS 16 001 Agency: HHS-AHRQ Category: Health Funding Amount: $1,000,000 |
| Novel Genomic Technology Development (R43/R44) Apply for PAR 16 016 Funding Number: PAR 16 016 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH16 1621", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
